Stock Markets November 19, 2026 03:00 AM

Anthropic Prices IPO at $83, Sets Nasdaq Listing for November 19, 2026

Company sells 980 million Class A shares; underwriters hold option for additional 147 million

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn

Anthropic, PBC has set the initial public offering price for its Class A common stock at $83.00 per share. The offering totals 980,000,000 shares, primarily sold by the company with a portion sold by existing stockholders. Shares are expected to begin trading on the Nasdaq Global Select Market under the ticker ANT on November 19, 2026, with the offering scheduled to close the following day, subject to customary closing conditions.

Anthropic Prices IPO at $83, Sets Nasdaq Listing for November 19, 2026
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Anthropic priced its Class A common stock IPO at $83.00 per share, covering 980,000,000 shares in total.
  • Of the shares offered, 956,351,354 are being sold by Anthropic and 23,648,646 are being sold by certain selling stockholders; Anthropic will not receive proceeds from the selling stockholders' shares. Sectors impacted include technology and capital markets.
  • Shares are expected to begin trading on the Nasdaq Global Select Market on November 19, 2026 under the ticker ANT, and the offering is expected to close on November 20, 2026, subject to customary closing conditions; underwriters have a 30-day option to buy up to an additional 147,000,000 shares.

Anthropic, PBC announced the pricing of its initial public offering of Class A common stock at a price of $83.00 per share. The planned offering comprises 980,000,000 shares of Class A common stock.

Of the 980,000,000 shares in the offering, 956,351,354 shares are being sold by Anthropic itself. An additional 23,648,646 shares are being offered by certain selling stockholders. The company has stated that it will not receive any proceeds from the shares sold by those selling stockholders.

Trading of Anthropic's Class A common stock is expected to commence on the Nasdaq Global Select Market on November 19, 2026. The company will use the ticker symbol "ANT" when its shares begin trading. The offering is expected to close on November 20, 2026, subject to the satisfaction of customary closing conditions.

Underwriters for the offering have been granted a 30-day option to purchase up to an additional 147,000,000 shares of Anthropic's Class A common stock. That option, if exercised, would increase the total number of shares sold in connection with the offering.


Context and remaining questions

The company release includes two open questions about market context: How have newly listed AI companies performed after their IPOs? And how does ANT's IPO pricing compare with recent technology listings? The announcement does not provide answers to those questions; they remain points for investors and analysts to evaluate independently.

What this means in plain terms

  • Anthropic has set a firm price for its Class A shares at $83.00 each and structured the offering for a total of 980,000,000 shares.
  • A substantial majority of the offered shares are being sold by the company, while a smaller tranche is being sold by existing stockholders, with proceeds from those sales not accruing to Anthropic.
  • The transaction includes the common underwriter option to add up to 147,000,000 additional shares within 30 days.

The announcement provides the core financing terms and the anticipated trading timetable, while leaving comparative and post-listing performance considerations to market participants and analysts.

Risks

  • The offering is subject to customary closing conditions, so the transaction could be delayed or may not close if those conditions are not satisfied - this affects capital markets and investors.
  • Anthropic will not receive proceeds from the shares sold by the selling stockholders, which affects the company's direct capital raise from the offering and may influence investor assessments in the technology sector.
  • The underwriters' 30-day option to purchase up to 147,000,000 additional shares could increase the total number of shares outstanding and has potential implications for dilution and market supply in the public markets.

More from Stock Markets

A2 Milk plunges after AGM downgrades H1 guidance as China volumes lag Nov 19, 2026 Exor to Boost Direct Holding in bioMérieux to 8.53% via Share Transfer Nov 19, 2026 KAP AG posts 5.5% revenue decline in first nine months of 2026, affirms full-year guidance Nov 19, 2026 L'Oréal Leads Consortium Seeking Combined 15% Stake in Armani Nov 19, 2026 Sony Shares Rise as Grand Theft Auto VI Dominates PlayStation Sales Nov 19, 2026